Search

Catherine R. Oliver-garcia

Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )

Most Active Art Unit
2914
Art Unit(s)
2904, 2900, 2914
Total Applications
7479
Issued Applications
7429
Pending Applications
0
Abandoned Applications
54

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6275735 [patent_doc_number] => 20020106634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for diagnosing a vascular condition' [patent_app_type] => new [patent_app_number] => 10/059920 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 19588 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106634.pdf [firstpage_image] =>[orig_patent_app_number] => 10059920 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/059920
Method for diagnosing a vascular condition Jan 28, 2002 Abandoned
Array ( [id] => 5935421 [patent_doc_number] => 20020061300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Method and composition for treating prostate cancer' [patent_app_type] => new [patent_app_number] => 10/055063 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9367 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061300.pdf [firstpage_image] =>[orig_patent_app_number] => 10055063 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/055063
Method and composition for treating prostate cancer Jan 21, 2002 Issued
Array ( [id] => 6527829 [patent_doc_number] => 20020192752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Compositions and methods for the treatment of immune related diseases' [patent_app_type] => new [patent_app_number] => 10/053107 [patent_app_country] => US [patent_app_date] => 2002-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 45172 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192752.pdf [firstpage_image] =>[orig_patent_app_number] => 10053107 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/053107
Compositions and methods for the treatment of immune related diseases Jan 16, 2002 Abandoned
Array ( [id] => 6750947 [patent_doc_number] => 20030045468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Compositions and methods for the therapy, diagnosis and monitoring of breast cancer' [patent_app_type] => new [patent_app_number] => 10/042945 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24291 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045468.pdf [firstpage_image] =>[orig_patent_app_number] => 10042945 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/042945
Compositions and methods for the therapy, diagnosis and monitoring of breast cancer Jan 7, 2002 Abandoned
Array ( [id] => 6740207 [patent_doc_number] => 20030157576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Epithelial cell growth inhibitors' [patent_app_type] => new [patent_app_number] => 10/028952 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6106 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157576.pdf [firstpage_image] =>[orig_patent_app_number] => 10028952 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/028952
Epithelial cell growth inhibitors Dec 17, 2001 Issued
Array ( [id] => 6178599 [patent_doc_number] => 20020156247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Mammalian checkpoint genes and proteins' [patent_app_type] => new [patent_app_number] => 10/020038 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18945 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156247.pdf [firstpage_image] =>[orig_patent_app_number] => 10020038 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/020038
Mammalian checkpoint genes and proteins Dec 11, 2001 Abandoned
Array ( [id] => 6865141 [patent_doc_number] => 20030190667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/015480 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 250 [patent_figures_cnt] => 250 [patent_no_of_words] => 283276 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190667.pdf [firstpage_image] =>[orig_patent_app_number] => 10015480 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/015480
Secreted and transmembrane polypeptides and nucleic acids encoding the same Dec 10, 2001 Issued
Array ( [id] => 6156697 [patent_doc_number] => 20020146396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells' [patent_app_type] => new [patent_app_number] => 10/014877 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 29125 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146396.pdf [firstpage_image] =>[orig_patent_app_number] => 10014877 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/014877
Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells Dec 10, 2001 Issued
Array ( [id] => 6628567 [patent_doc_number] => 20020086408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Ubiquitin-like conjugating protein' [patent_app_type] => new [patent_app_number] => 10/013742 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19846 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086408.pdf [firstpage_image] =>[orig_patent_app_number] => 10013742 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/013742
Ubiquitin-like conjugating protein Dec 6, 2001 Abandoned
Array ( [id] => 6706192 [patent_doc_number] => 20030152926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators' [patent_app_type] => new [patent_app_number] => 10/021660 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69752 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152926.pdf [firstpage_image] =>[orig_patent_app_number] => 10021660 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/021660
Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators Dec 5, 2001 Abandoned
Array ( [id] => 1022032 [patent_doc_number] => 06887975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Peptides derived from STEAP1' [patent_app_type] => utility [patent_app_number] => 10/010667 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 20757 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887975.pdf [firstpage_image] =>[orig_patent_app_number] => 10010667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/010667
Peptides derived from STEAP1 Dec 5, 2001 Issued
Array ( [id] => 6110919 [patent_doc_number] => 20020172935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors' [patent_app_type] => new [patent_app_number] => 10/010762 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14771 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172935.pdf [firstpage_image] =>[orig_patent_app_number] => 10010762 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/010762
Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors Dec 5, 2001 Abandoned
Array ( [id] => 695767 [patent_doc_number] => 07071304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 10/006117 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 249 [patent_figures_cnt] => 249 [patent_no_of_words] => 279663 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071304.pdf [firstpage_image] =>[orig_patent_app_number] => 10006117 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/006117
Secreted and transmembrane polypeptides and nucleic acids encoding the same Dec 5, 2001 Issued
Array ( [id] => 6751161 [patent_doc_number] => 20030045682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Antibodies immunospecific for STEAP1' [patent_app_type] => new [patent_app_number] => 10/011095 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21019 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045682.pdf [firstpage_image] =>[orig_patent_app_number] => 10011095 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/011095
Antibodies immunospecific for STEAP1 Dec 5, 2001 Issued
Array ( [id] => 6860548 [patent_doc_number] => 20030091556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods of inhibiting tumor growth and angiogenesis with anastellin' [patent_app_type] => new [patent_app_number] => 10/005171 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10388 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091556.pdf [firstpage_image] =>[orig_patent_app_number] => 10005171 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005171
Methods of inhibiting tumor growth and angiogenesis with anastellin Dec 2, 2001 Abandoned
Array ( [id] => 6157832 [patent_doc_number] => 20020146804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use' [patent_app_type] => new [patent_app_number] => 09/989903 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17367 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146804.pdf [firstpage_image] =>[orig_patent_app_number] => 09989903 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/989903
Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use Nov 19, 2001 Issued
Array ( [id] => 6378070 [patent_doc_number] => 20020119531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Prostate-associated protease antibody' [patent_app_type] => new [patent_app_number] => 09/988975 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14564 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119531.pdf [firstpage_image] =>[orig_patent_app_number] => 09988975 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/988975
Prostate-associated protease antibody Nov 18, 2001 Abandoned
Array ( [id] => 6813540 [patent_doc_number] => 20030073090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/990439 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 331 [patent_figures_cnt] => 331 [patent_no_of_words] => 289205 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073090.pdf [firstpage_image] =>[orig_patent_app_number] => 09990439 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/990439
Nucleic acids encoding PRO830 Nov 15, 2001 Issued
Array ( [id] => 946689 [patent_doc_number] => 06965023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Death domain proteins' [patent_app_type] => utility [patent_app_number] => 10/001254 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 33033 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/965/06965023.pdf [firstpage_image] =>[orig_patent_app_number] => 10001254 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/001254
Death domain proteins Nov 14, 2001 Issued
09/913557 Peptides Nov 6, 2001 Abandoned
Menu